Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
ACON
ACON
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ACON News
Aclarion Partners with Weill Cornell for Lumbar Surgery Study
5d ago
NASDAQ.COM
ACLARION SIGNS SECOND COMMERCIAL DEAL WITH WEILL CORNELL MEDICINE
5d ago
moomoo
Aclarion Reports 196% Year-over-Year Growth in Nociscan Volumes for Q1 2026
May 01 2026
seekingalpha
Aclarion Appoints New Commercial Director to Drive Growth
Apr 28 2026
Newsfilter
Aclarion Announces $2.5 Million Share Repurchase Program
Apr 22 2026
seekingalpha
Aclarion Authorizes $2.5 Million Share Repurchase Program
Apr 22 2026
NASDAQ.COM
ACLARION REVEALS PARTNERSHIP WITH WEILL CORNELL MEDICINE
Apr 08 2026
moomoo
Aclarion Releases 2026 Shareholder Letter Highlighting Key Milestones
Feb 05 2026
Newsfilter
Aclarion CEO Outlines 2026 Execution Plan Focused on Reimbursement and Adoption
Feb 04 2026
stocktwits
Aclarion Expands Nociscan Availability in Greater Los Angeles
Feb 03 2026
Newsfilter
Aclarion, Inc. Closes $10.4 Million Financing, Extends Cash Runway to 2028
Jan 13 2026
Benzinga
Aclarion Closes $10.4 Million Financing, Extends Cash Runway to 2028
Jan 13 2026
Globenewswire
U.S. Nonfarm Payrolls Increase by 50,000, Unemployment Rate Drops to 4.4%
Jan 09 2026
Benzinga
WD-40 Co Reports Q1 Earnings Miss, Shares Drop 9.1%
Jan 09 2026
Benzinga
Tilray Brands Reports Q2 Earnings Beat, Shares Surge 7.3%
Jan 09 2026
Benzinga
Aclarion (ACON) Shares Surge 50% Following 2025 Business Update and 2026 Outlook
Jan 08 2026
NASDAQ.COM
Show More News
